Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Did you get a letter fromHealth Canada saying next 2 months

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Oct 28, 2021 7:55pm

117 Views

Post# 34061335

Did you get a letter fromHealth Canada saying next 2 months

Just can't stand the forward assuming statements , Intelgenx down today on little volume , that is the 90 million dollar company you are betting on not Tetra , Intelgenx is doing the study and making the drug, YOU HAVE NO IDEA WHEN OR IF APPROVAL WILL HAPPEN .Pump Pump Pump Seems like you know every thing except why the CFO quit and where the Ontario office is.

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions